Efficacy and safety of darunavir (Prezista®) with low-dose ritonavir and other antiretroviral medications in subtype F HIV-1 infected, treatment-experienced subjects in Romania: a post-authorization, open-label, one-cohort, non-interventional, prospective study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Efficacy and safety of darunavir (Prezista®) with low-dose ritonavir and other antiretroviral medications in subtype F HIV-1 infected, treatment-experienced subjects in Romania: a post-authorization, open-label, one-cohort, non-interventional, prospective study

Published:2014-09 Issue:3 Volume:4 Page:59-69
ISSN:2248-2997
Container-title:GERMS
language:
Short-container-title:GERMS

Author:

Benea Otilia Elisabeta,Streinu-Cercel Adrian,Dorobăț Carmen,Rugină Sorin,Negruțiu Lucian,Cupșa Augustin,Duiculescu Dan,Chiriac Carmen,Itu Corina,Prisăcariu Liviu Jany,Iosif Ionel

Publisher

Asociatia Pentru Cresterea Vizibilitatii Cercetarii Stiintifice (ACVCS)

Subject

Infectious Diseases,Microbiology (medical),Public Health, Environmental and Occupational Health,General Immunology and Microbiology,Epidemiology

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety and Effectiveness of Darunavir in Korean Patients with Human Immunodeficiency Virus 1 Infection: A Post-Marketing Observational Study;Infection & Chemotherapy;2021

2. Long-term clinical experience with darunavir (2007-2015) in a large cohort of HIV-infected patients in Spain;Journal of Medical Virology;2016-06-06

3. Effectiveness, durability, and safety of darunavir/ritonavir in HIV-1-infected patients in routine clinical practice in Italy: a postauthorization noninterventional study;Drug Design, Development and Therapy;2016-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP